We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
87.75%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$768M
AUM Growth
+$22.8M
(+3.1%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
3.42%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,093
New
800
Increased
114
Reduced
121
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.93M |
| 2 |
CACI
CACI
|
+$5.05M |
| 3 |
CELG
Celgene Corp
CELG
|
+$4.9M |
| 4 |
Yelp
YELP
|
+$4.72M |
| 5 |
Norfolk Southern
NSC
|
+$4.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradata
TDC
|
+$6.01M |
| 2 |
Gilead Sciences
GILD
|
+$5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.91M |
| 4 |
Copa Holdings
CPA
|
+$4.6M |
| 5 |
Lowe's Companies
LOW
|
+$4.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.19% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.55% |
| 4 | Industrials | 12.49% |
| 5 | Consumer Discretionary | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KND
601
DELISTED
Kindred Healthcare
KND
| $20K | ﹤0.01% |
+2,187
| New | +$20.2K |
|
602
AstraZeneca
AZN
$250B
| $19K | ﹤0.01% |
+274
| New | +$19K |
|
603
Bath & Body Works
BBWI
$4.1B
| $19K | ﹤0.01% |
+607
| New | +$23K |
|
604
GSK
GSK
$106B
| $19K | ﹤0.01% |
+385
| New | +$17.9K |
|
605
Leidos
LDOS
$17.3B
| $19K | ﹤0.01% |
+285
| New | +$18.8K |
|
606
Landstar System
LSTR
$6.21B
| $19K | ﹤0.01% |
+175
| New | +$19.2K |
|
607
StoneX
SNEX
$7.94B
| $19K | ﹤0.01% |
+2,222
| New | +$18.7K |
|
608
TD Synnex
SNX
$20.2B
| $19K | ﹤0.01% |
+324
| New | +$20.2K |
|
609
Toronto Dominion Bank
TD
$200B
| $19K | ﹤0.01% |
+327
| New | +$19.1K |
|
|
SC
610
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $19K | ﹤0.01% |
+1,177
| New | +$20.3K |
|
611
Ashland
ASH
$3.5B
| $18K | ﹤0.01% |
+257
| New | +$18.5K |
|
612
First Citizens BancShares
FCNCA
$25.3B
| $18K | ﹤0.01% |
+44
| New | +$19K |
|
613
Fidelity National Financial
FNF
$13.5B
| $18K | ﹤0.01% |
+480
| New | +$18.3K |
|
614
Honda
HMC
$41.3B
| $18K | ﹤0.01% |
+506
| New | +$17.9K |
|
615
Mercury Insurance
MCY
$6.07B
| $18K | ﹤0.01% |
+397
| New | +$18.9K |
|
616
Sally Beauty Holdings
SBH
$1.58B
| $18K | ﹤0.01% |
+1,090
| New | +$18.7K |
|
|
DF
617
DELISTED
Dean Foods Company
DF
| $18K | ﹤0.01% |
+2,055
| New | +$20.3K |
|
618
Atmos Energy
ATO
$28.8B
| $17K | ﹤0.01% |
+198
| New | +$16.1K |
|
619
British American Tobacco
BTI
$128B
| $17K | ﹤0.01% |
+294
| New | +$18.5K |
|
620
Celanese
CE
$4.82B
| $17K | ﹤0.01% |
+173
| New | +$18.3K |
|
621
Goodyear
GT
$1.85B
| $17K | ﹤0.01% |
+633
| New | +$19.6K |
|
622
Mitsubishi UFJ Financial
MUFG
$254B
| $17K | ﹤0.01% |
+2,580
| New | +$18.8K |
|
623
Prudential
PUK
$35.2B
| $17K | ﹤0.01% |
+344
| New | +$17.4K |
|
624
Banco Santander
SAN
$210B
| $17K | ﹤0.01% |
+2,743
| New | +$18.2K |
|
625
TotalEnergies
TTE
$190B
| $17K | ﹤0.01% |
+27,121
| New | +$17K |
|
Similar funds
MWA
SFP
ECM
NRG
HW
LAM
BGIM
CIA
Convergence Investment Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Convergence Investment Partners held 1,093 positions worth $768M, up 3.1% from $745M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Convergence Investment Partners deployed $26.3M of net new capital in Q1 2018, opening 800 new positions and adding to 114 existing holdings. Its largest new stake was CACI: 34,563 shares worth $5.23M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Teradata, an estimated $6.01M trimmed.
- Convergence Investment Partners's largest Q1 2018 buy was CACI: 34,563 shares worth $5.23M.
- Convergence Investment Partners added most to Pfizer in Q1 2018, an estimated $5.93M increase.
- Convergence Investment Partners's biggest Q1 2018 reduction was Teradata, cutting an estimated $6.01M.
- Convergence Investment Partners fully exited Ingevity in Q1 2018, selling an estimated $3.95M.
- Convergence Investment Partners's ten largest holdings make up 13% of its $768M portfolio in Q1 2018.
- Convergence Investment Partners opened 800 new positions and closed 54 in Q1 2018.
- Convergence Investment Partners's portfolio value rose 3.1% quarter-over-quarter to $768M.
Based on Convergence Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.